Botulinum Neurotoxin: Shared/Common Mechanisms in the Treatment of Pain, Spasticity and Movement Disorders
This special issue belongs to the section "Bacterial Toxins".
Special Issue Information
Dear Colleagues,
Botulinum neurotoxin (BoNT) is an established and licensed treatment in a number of clinical conditions in neurology, neurorehabilitation and pain medicine, including, e.g., spasticity, dystonia, other movement disorders, chronic migraines, neuropathic pain, and other headache and pain disorders.
This Special Issue aims to present the state-of-the-art therapeutic mechanisms and indications in pain, spasticity, movement disorders, and combined clinical conditions.
Appropriate submissions for this Special Issue include reviews, systematic reviews and meta-analyses, as well as original studies. Preclinical, clinical and experimental studies in humans will be welcome.
Prof. Dr. Giorgio Sandrini
Prof. Dr. Stefano Tamburin
Dr. Roberto De Icco
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a double-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Toxins is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- botulinum toxin
- pain
- headache
- spasticity
- movement disorders
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Published Papers
Toxins - ISSN 2072-6651